1
|
Kawai F. Somatic ion channels and action potentials in olfactory receptor cells and vomeronasal receptor cells. J Neurophysiol 2024; 131:455-471. [PMID: 38264787 DOI: 10.1152/jn.00137.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 01/10/2024] [Accepted: 01/17/2024] [Indexed: 01/25/2024] Open
Abstract
Olfactory receptor cells are primary sensory neurons that catch odor molecules in the olfactory system, and vomeronasal receptor cells catch pheromones in the vomeronasal system. When odor or pheromone molecules bind to receptor proteins expressed on the membrane of the olfactory cilia or vomeronasal microvilli, receptor potentials are generated in their receptor cells. This initial excitation is transmitted to the soma via dendrites, and action potentials are generated in the soma and/or axon and transmitted to the central nervous system. Thus, olfactory and vomeronasal receptor cells play an important role in converting chemical signals into electrical signals. In this review, the electrophysiological characteristics of ion channels in the somatic membrane of olfactory receptor cells and vomeronasal receptor cells in various species are described and the differences between the action potential dynamics of olfactory receptor cells and vomeronasal receptor cells are compared.
Collapse
Affiliation(s)
- Fusao Kawai
- Department of Physiology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan
| |
Collapse
|
2
|
Shiga H, Wakabayashi H, Washiyama K, Noguchi T, Hiromasa T, Miyazono S, Kumai M, Ogawa K, Taki J, Kinuya S, Miwa T. Thallium-201 Imaging in Intact Olfactory Sensory Neurons with Reduced Pre-Synaptic Inhibition In Vivo. Mol Neurobiol 2020; 57:4989-4999. [PMID: 32820461 PMCID: PMC7541386 DOI: 10.1007/s12035-020-02078-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 08/14/2020] [Indexed: 11/30/2022]
Abstract
In this study, we determined whether the 201Tl (thallium-201)-based olfactory imaging is affected if olfactory sensory neurons received reduced pre-synaptic inhibition signals from dopaminergic interneurons in the olfactory bulb in vivo. The thallium-201 migration rate to the olfactory bulb and the number of action potentials of olfactory sensory neurons were assessed 3 h following left side nasal administration of rotenone, a mitochondrial respiratory chain complex I inhibitor that decreases the number of dopaminergic interneurons without damaging the olfactory sensory neurons in the olfactory bulb, in mice (6–7 animals per group). The migration rate of thallium-201 to the olfactory bulb was significantly increased following intranasal administration of thallium-201 and rotenone (10 μg rotenone, p = 0.0012; 20 μg rotenone, p = 0.0012), compared with that in control mice. The number of action potentials was significantly reduced in the olfactory sensory neurons in the rotenone treated side of 20 μg rotenone-treated mice, compared with that in control mice (p = 0.0029). The migration rate of thallium-201 to the olfactory bulb assessed with SPECT-CT was significantly increased in rats 24 h after the left intranasal administration of thallium-201 and 100 μg rotenone, compared with that in control rats (p = 0.008, 5 rats per group). Our results suggest that thallium-201 migration to the olfactory bulb is increased in intact olfactory sensory neurons with reduced pre-synaptic inhibition from dopaminergic interneurons in olfactory bulb glomeruli.
Collapse
Affiliation(s)
- Hideaki Shiga
- Department of Otorhinolaryngology, Kanazawa Medical University, Uchinadamachi, Kahokugun, Ishikawa, 920-0293, Japan.
| | - Hiroshi Wakabayashi
- Department of Nuclear Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan
| | - Kohshin Washiyama
- Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, 960-1295, Japan
| | - Tomohiro Noguchi
- Department of Sensory Physiology, Asahikawa Medical University, Asahikawa, 078-8510, Japan
| | - Tomo Hiromasa
- Department of Nuclear Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan
| | - Sadaharu Miyazono
- Department of Sensory Physiology, Asahikawa Medical University, Asahikawa, 078-8510, Japan
| | - Masami Kumai
- Department of Otorhinolaryngology, Kanazawa Medical University, Uchinadamachi, Kahokugun, Ishikawa, 920-0293, Japan
| | - Kazuma Ogawa
- Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, 920-1192, Japan
| | - Junichi Taki
- Department of Nuclear Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan
| | - Seigo Kinuya
- Department of Nuclear Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan
| | - Takaki Miwa
- Department of Otorhinolaryngology, Kanazawa Medical University, Uchinadamachi, Kahokugun, Ishikawa, 920-0293, Japan
| |
Collapse
|